Journalist Jon Mooallem noticed that his young daughter was always surrounded by wild animals: butterflies on her pajamas, a stuffed toy owl, and beavers in her bedtime stories. But these romantic portrayals, he says, hid a harsh reality. Scientists estimate half of all species could be gone by the turn of the century. So he embarked on his own journey to track down three endangered animals, and discovered the extreme -- even futile -- lengths humans go to save them. Jon Mooallem discusses his book, "Wild Ones," and the complex intersections of man and nature.
A new edition of the most widely used psychiatric guide to mental disorders -- "The Diagnostic and Statistical Manual of Mental Disorders" -- was released this past weekend in San Francisco at a meeting of the American Psychiatric Association. The manual has a big impact on public health, including what insurance companies will cover, the drugs that regulators will approve, and even which children will receive special education services. But critics say that the manual is outdated and question the validity of several new diagnoses.
In 2011, a National Academy of Sciences report called for the creation of a "knowledge network of disease" to help researchers and doctors share information and patient data more effectively. Such a network would also allow scientists and clinicians to access data on the molecular makeup of diseases, vastly improving diagnosis and treatment. But the concept -- known as "precision medicine" -- is already raising ethical questions and concerns over patient privacy. We talk to the heads of National Institutes of Health, the Food and Drug Administration and UCSF about precision medicine, the subject of a two-day summit in San Francisco this week.